BlendsHealing

BPC-157 5mg + TB-500 5mg

Peptide blend · BPC-157 + Thymosin Beta-4 · Synthetic

FDA · CATEGORY 2 (2023)

Half-life

~5 hours

Short

minsdays

Route

SubQ injection

Evidence

Preclinical only

Risk

Standard

Jeremy Renner Jeremy RennerActor · Marvel Avengers

I was told I might not walk normally again. BPC-157 was a game changer — I'm now training for a marathon.

Thymosin Alpha-1Thymosin Alpha-1ImmuneLongevity

Reference only — not an endorsement.

Overview

Known for

The standard healing stack pre-blended. Combines localised tissue repair (BPC) with systemic healing and cell migration (TB-500). Ideal for injury recovery, joint health, and faster return to training.

Mechanism

Combined healing stack — BPC-157 (local, gut, tendon) + TB-500 (systemic, cardiac, anti-inflammatory). Complementary mechanisms.

Key facts

Format
Lyophilized powder
Mechanism targets
Classification
Secondary
Supply & nature
Natural / Topping UpNatural
FDA category
Category 2 (2023)

Evidence & standing

Evidence base
Preclinical only
Risk level
Standard
Best studies
3 references
  • No published studies on this specific combination
  • Based on individual component research (see BPC-157 and TB-500 entries)
  • NOT FDA APPROVED

Dosage & protocol

Typical dose
250-500mcg
Cycle
4 weeks on / 2 weeks off
Onset
5 days first effects
Full effect
42 days
Half-life
~4h / ~4-6h
BPC: ~4hrs | TB-500: ~4-6hrs
Protocol

5-10 units daily with 2ml BAC water (250-500mcg of each per dose). SubQ near injury or abdominally.

Time to effects

EARLY: 3-7 days

FULL: 4-8 weeks

Combines the fast onset of BPC-157 with the systemic healing of TB-500.

Day 3-7: Pain reduction and inflammation improvements (BPC effect).

Week 1-2: Healing acceleration noticeable.

Week 4-8: Major injury recovery. Flexibility improvements.

Minimum commitment: 4 weeks.

Recommended vial
  • 5mg+5mg per vial

At 10 units/day (2ml BAC) = ~10 days ✓. No shelf life issues.

Reference figures only

Dosing reflects published laboratory protocols and is not guidance for use in any living subject.

Safety

Reversibility
Fully Reversible
Side effects

Combined: headache, flushing, mild GI. Generally well-tolerated.

Interactions

Unknown

Do not combine
BPC-157BPC-157 BPC-157 10mg + TB-500 10mg (Blend)BPC-157 10mg + TB-500 10mg (Blend) GLOW Blend (BPC 10mg + TB 10mg + GHK-Cu 50mg)GLOW Blend (BPC 10mg + TB 10mg + GHK-Cu 50mg) KLOW Blend (BPC 10mg + TB 10mg + GHK-Cu 50mg + KPV 10mg)KLOW Blend (BPC 10mg + TB 10mg + GHK-Cu 50mg + KPV 10mg) TB-500 (Thymosin Beta-4 Acetate)TB-500 (Thymosin Beta-4 Acetate)

Handle with research caution

  • Avoid NSAIDs during use
  • Avoid if active cancer/tumour history (angiogenesis concern)

Storage & handling

Lyophilised
12–24 months
2–8°C
Reconstituted
4–6 weeks
2–8°C

Videos & talks

Independent educational content from researchers, clinicians and science communicators — not affiliated with Pepnerd.

Educational resources only. Videos are independent third-party content. Pepnerd is not affiliated with these creators and does not endorse or make claims based on their content. All products are for in-vitro research.